2-Chloro-N'-(2-chloroacetyl)benzohydrazide

Catalog No. :
ACNLYZ944
CAS No. :
52093-13-7
Molecular Formula :
C9H8Cl2N2O2
Molecular Weight :
247.08

IUPAC Name:2-chloro-N'-(2-chloroacetyl)benzohydrazide

2-Chloro-N'-(2-chloroacetyl)benzohydrazide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$56.00Login to see priceIn stockInquiry
250mg95%$130.00Login to see priceIn stockInquiry
1g95%$217.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-N'-(2-chloroacetyl)benzohydrazide
IUPAC Name2-chloro-N'-(2-chloroacetyl)benzohydrazide
MDL No.MFCD07310137
Molecular FormulaC9H8Cl2N2O2
Molecular Weight247.08
SMILESO=C(NNC(CCl)=O)C1=CC=CC=C1Cl
InChI KeyUJMJNAWUKFYFQN-UHFFFAOYSA-N
Synonym2-chloro-N'-(2-chloroacetyl)benzohydrazide;Reaxys ID: 1981227;Benzoic acid, 2-chloro-, 2-(2-chloroacetyl)hydrazide;2-chloro-N′-(chloroacetyl)benzohydrazide, CAS 52093-13-7
CAS No.52093-13-7

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H312-H315-H318-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACNLYZ944 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCSRN601 route compound structure diagram
    ACCSRN6015814-05-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNLYZ944 route product structure diagram
    ACNLYZ94452093-13-7 In Stock
Inquiry

2. ACNLYZ944 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCSRN601 route compound structure diagram
    ACCSRN6015814-05-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNLYZ944 route product structure diagram
    ACNLYZ94452093-13-7 In Stock
Inquiry

Comments (0)